Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2009 Mar 22;120(1):25–34. doi: 10.1007/s10549-009-0357-6

Figure 3. Cancer progression in Ma et al’s study by comparison of the malignancy-risk score among AHD, DCIS, and IDC.

Figure 3

The first panel displayed distribution of the malignancy-risk score among the three groups: ADH, DCIS, and IDC. The 2nd panel was 95% confidence interval of pair-wise comparison for the risk score among the three groups with adjusted p value in the right-hand side’s y axis.